High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study (Q44585429)
Jump to navigation
Jump to search
scientific article published on 15 September 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study |
scientific article published on 15 September 2003 |
Statements
1 reference
High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study (English)
1 reference
Peter Libby
1 reference
Nader Rifai
1 reference
Scott Kinlay
1 reference
Gregory G Schwartz
1 reference
Anders G Olsson
1 reference
Sally J Leslie
1 reference
William J Sasiela
1 reference
Michael Szarek
1 reference
Peter Ganz
1 reference
Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering Study Investigators
1 reference
15 September 2003
1 reference
1 reference
Identifiers
1 reference